| Total sample (n = 401) | Study purpose | |||
---|---|---|---|---|---|
Surveillance (n = 60) | Epidemiologic (n = 127) | Methodological (n = 103) | Quality improvement (n = 134) | ||
Cancer risk factor | 167 (41.7%) | 31 (51.7%) | 67 (52.8%) | 54 (52.4%) | 36 (26.9%) |
 Adult obesity | 64 (16.0%) | 13 (21.7%) | 29 (22.8%) | 24 (23.3%) | 10 (7.5%) |
 Childhood obesity | 29 (7.2%) | 15 (25.0%) | 8 (6.3%) | 7 (6.8%) | 3 (2.2%) |
 Smoking status | 98 (24.4%) | 13 (21.7%) | 46 (36.2%) | 35 (34.0%) | 18 (13.4%) |
 Other | 52 (13.0%) | 2 (3.3%) | 26 (20.5%) | 11 (10.7%) | 17 (12.7%) |
Screening and Immunization | 146 (36.4%) | 23 (38.3%) | 42 (33.1%) | 21 (20.4%) | 59 (44.0%) |
 Breast cancer Screening | 38 (9.5%) | 6 (10.0%) | 16 (12.6%) | 2 (1.9%) | 12 (9.0%) |
 Cervical cancer screening | 39 (9.7%) | 8 (13.3%) | 15 (11.8%) | 2 (1.9%) | 15 (11.2%) |
 HPV vaccination | 38 (9.5%) | 7 (11.7%) | 12 (9.5%) | 2 (1.9%) | 21 (15.7%) |
 Colorectal cancer screening | 82 (20.5%) | 8 (13.3%) | 21 (16.5%) | 16 (15.5%) | 36 (26.9%) |
 Other | 26 (6.5%) | 10 (16.7%) | 5 (3.9%) | 4 (3.9%) | 8 (6.0%) |
Referral to care | 64 (16.0%) | 8 (13.3%) | 12 (9.5%) | 8 (7.8%) | 28 (20.9%) |
 Breast cancer | 17 (4.2%) | 2 (3.3%) | 4 (3.2%) | 2 (1.9%) | 4 (3.0%) |
 Cervical cancer | 11 (2.7%) | 3 (5.0%) | 4 (3.2%) | 1 (1.0%) | 4 (3.0%) |
 Colorectal cancer | 25 (6.2%) | 2 (3.3%) | 3 (2.4%) | 3 (2.9%) | 12 (9.0%) |
 Other | 22 (5.5%) | 3 (5.0%) | 4 (3.2%) | 3 (2.9%) | 12 (9.0%) |
Incidence/prevalence | 93 (23.2%) | 10 (16.7%) | 31 (24.4%) | 28 (27.2%) | 22 (16.4%) |
 Breast cancer | 29 (7.2%) | 2 (3.3%) | 14 (11.0%) | 8 (7.8%) | 2 (1.5%) |
 Cervical cancer | 10 (2.5%) | 2 (3.3%) | 6 (4.7%) | 2 (1.9%) | 1 (0.8%) |
 Colorectal cancer | 39 (9.7%) | 3 (5.0%) | 8 (6.3%) | 15 (14.6%) | 10 (7.5%) |
 Other | 42 (10.5%) | 6 (10.0%) | 13 (10.2%) | 16 (15.5%) | 11 (8.2%) |